Appeals court restricts access to abortion pills across the US

Federal Appeals Court Limits Abortion Pill Access Nationwide

A federal appeals court has issued a ruling limiting access to abortion pills nationwide. The decision, made by the US Court of Appeals for the District of Columbia Circuit, temporarily halts mail-order access to abortion drugs.

The ruling affects the FDA’s 2016 rule allowing women to obtain abortion pills by mail without a prescription from a healthcare provider. The court’s decision does not immediately affect existing prescriptions or medical care received before the ruling took effect.

The appeals court’s decision is part of an ongoing debate over reproductive rights and access to abortion services in the United States. The FDA had previously approved mifepristone, a medication used in combination with another pill to induce abortion, for use by mail.

The ruling does not specify when or if the restrictions will be lifted. The court’s decision is subject to further review and appeal.

Source: Google News World